Global Artificial Intelligence in Drug Discovery Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Artificial Intelligence in Drug Discovery Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global artificial intelligence in drug discovery market has been segmented on the basis of application, therapeutic area, as well as regions and countries.
Generally, Artificial Intelligence (AI) is anything a computer can do that formerly was considered a job for a human, except, the pace of change in computing is what makes the difference. Artificial intelligence in drug discovery helps in identifying drug targets, find good molecules from data libraries, suggest chemical modifications, identify candidates for repurposing, etc.
In recent years, the growing need to lower the cost of novel drug discovery and production is a primary factor that is expected to fuel the revenue growth of the global artificial intelligence in drug discovery market over the next 10 years.
Moreover, there are vast amounts of data that is generated during the molecule screening processes and preclinical studies, which must be processed. The use of AI simplifies the process of collating and analyzing this data, thereby, lowering the screening process timeline, and reducing costs as a result.
In light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global artificial intelligence in drug discovery industry is no different, however, given the graveness of these present circumstances, the need to lower time required for in-depth analysis is of paramount importance. This is another factor that is anticipated to boost the revenue growth of the global artificial intelligence in drug discovery market in the near future.
Preclinical testing is an area that usually results in high revenue loss and low returns, as such, the need to optimize the preclinical testing phase is a significant factor that is expected to further augment market growth of this global industry in the years to come.
Segmentation of the global artificial intelligence in drug discovery market is as follows:
In terms of therapeutic area, the oncology segment accounted for the maximum number of revenue shares of the global artificial intelligence in drug discovery market in 2020. The infectious disease application segment is also anticipated to index a considerably high CAGR over the next 10 years.
On the basis of application, the drug optimization & repurposing segment constituted the majority number of revenue shares of the global artificial intelligence in drug discovery market in 2020. The preclinical testing segment is also slated to index considerable revenue growth over the next decade.
Regional Segmentation and Analysis:
North America accounted for the highest number of revenue shares of the global artificial intelligence in drug discovery market in 2020. This can be attributed to the general adoption of AI systems, as well as the large presence of industry players in this region. However, the markets in the Asia Pacific region are anticipated to register the fastest rate of revenue growth in the near future.
Segmentation of the Global Artificial Intelligence in Drug Discovery Market:
Segmentation by Application:
- Drug optimization and repurposing
- Preclinical testing
Segmentation by Therapeutic Area:
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
Segmentation by Regions:
- North America
- South America
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- IBM Watson
- Exscientia Ltd.
- GNS Healthcare
- Alphabet Inc. (DeepMind)
- Benevolent AI
- Berg Health LLC
- Atomwise Inc.
- Insitro Inc.
- Cyclica Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!